The pathology of t cells in systemic lupus erythematosus

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Mak, Anselm ^a,b   Kow, Nien Yee ^b  

^a University Medicine Cluster   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AUTOANTIBODY; CALCINEURIN INHIBITOR; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; IMMUNOLOGIC FACTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CELL COUNT; CLINICAL EVALUATION; DNA METHYLATION; DRUG EFFICACY; DRUG SAFETY; EPIGENETICS; GAMMA DELTA T LYMPHOCYTE; HELPER CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENICITY; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; CLINICAL TRIAL (TOPIC); GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOUSE; PATHOLOGY;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CALCINEURIN INHIBITORS; CELL COMMUNICATION; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84901001162     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/419029     Document Type: Review

References (74)

1. Tsokos G. C., Mechanisms of disease: systemic lupus erythematosus. The New England Journal of Medicine 2011 365 22 2110 2121 2-s2.0-82555196095
2. Liu Z., Davidson A., BAFF and selection of autoreactive B cells. Trends in Immunology 2011 32 8 388 394 2-s2.0-79960918034 10.1016/j.it.2011.06.004
3. Shlomchik M. J., Craft J. E., Mamula M. J., From T to B and back again: positive feedback in systemic autoimmune disease. Nature Reviews Immunology 2001 1 2 147 153 2-s2.0-0035525528 (Pubitemid 33741968)
4. Moulton V. R., Tsokos G. C., Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Research and Therapy 2011 13 2, article 207 2-s2.0-80053286823 10.1186/ar3251
5. Crispín J. C., Kyttaris V. C., Juang Y.-T., Tsokos G. C., How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends in Immunology 2008 29 3 110 115 2-s2.0-39749089837 10.1016/j.it.2007.12.003
6. Crispín J. C., Tsokos G. C., Wallace D. J., Hahn B. H., T cells. Dubois' Lupus Erythematosus and Related Syndromes 2013 8th Amsterdam, The Netherlands Elvesier 96 103
7. Sawla P., Hossain A., Hahn B. H., Singh R. P., Regulatory T cells in systemic lupus erythematosus (SLE); Role of peptide tolerance. Autoimmunity Reviews 2012 11 9 611 614 2-s2.0-84860598648 10.1016/j.autrev.2011.09.008
8. Dinesh R. K., Skaggs B. J., La Cava A., Hahn B. H., Singh R. P., CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmunity Reviews 2010 9 8 560 568 2-s2.0-77952743515 10.1016/j.autrev.2010.03.006
9. Bentley G. A., Mariuzza R. A., The structure of the T cell antigen receptor. Annual Review of Immunology 1996 14 563 590 2-s2.0-0029935523 10.1146/annurev.immunol.14.1.563 (Pubitemid 26130195)
10. Hayday A. C., γ δ cells: a right time and a right place for a conserved third way of protection. Annual Review of Immunology 2000 18 975 1026 2-s2.0-0034091286 10.1146/annurev.immunol.18.1.975 (Pubitemid 30365402)
11. Chien Y. H., Jores R., Crowley M. P., Recognition by gamma/delta T cells. Annual Review of Immunology 1996 14 511 532
12. José E. S., Sahuquillo A. G., Bragado R., Alarcón B., Assembly of the TCR/CD3 complex: CD3 epsilon/delta and CD3 epsilon/gamma dimers associate indistinctly with both TCR alpha and TCR beta chains. Evidence for a double TCR heterodimer model. European Journal of Immunology 1998 28 1 12 21 (Pubitemid 28048272)
13. Weiss A., Littman D. R., Signal transduction by lymphocyte antigen receptors. Cell 1994 76 2 263 274 2-s2.0-0028014460 10.1016/0092-8674(94)90334-4 (Pubitemid 24046689)
14. Deindl S., Kadlecek T. A., Brdicka T., Cao X., Weiss A., Kuriyan J., Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell 2007 129 4 735 746 2-s2.0-34249105476 10.1016/j.cell.2007.03.039 (Pubitemid 46802380)
15. Krishnan S., Juang Y.-T., Chowdhury B., Magilavy A., Fisher C. U., Nguyen H., Nambiar M. P., Kyttaris V., Weinstein A., Bahjat R., Pine P., Rus V., Tsokos G. C., Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. Journal of Immunology 2008 181 11 8145 8152 2-s2.0-58149308537
16. Enyedy E. J., Nambiar M. P., Liossis S. N., Dennis G., Kammer G. M., Tsokos G. C., Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis & Rheumatology 2001 44 5 1114 1121 (Pubitemid 32433617)
17. Ghosh D., Tsokos G. C., Kyttaris V. C., C-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells. Journal of Biological Chemistry 2012 287 15 11833 11841 2-s2.0-84859496039 10.1074/jbc.M111.333997
18. Liossis S. N., Ding X. Z., Dennis G. J., Tsokos G. C., Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. The Journal of Clinical Investigation 1998 101 7 1448 1457 2-s2.0-0032036481 (Pubitemid 28166843)
19. Krishnan S., Kiang J. G., Fisher C. U., Nambiar M. P., Nguyen H. T., Kyttaris V. C., Chowdhury B., Rus V., Tsokos G. C., Increased caspase-3 expression and activity contribute to reduced CD3 ζ expression in systemic lupus erythematosus T cells. Journal of Immunology 2005 175 5 3417 3423 2-s2.0-23844449332 (Pubitemid 41170565)
20. Moulton V. R., Kyttaris V. C., Juang Y.-T., Chowdhury B., Tsokos G. C., The RNA-stabilizing protein HuR regulates the expression of ζ chain of the human T cell receptor-associated CD3 complex. Journal of Biological Chemistry 2008 283 29 20037 20044 2-s2.0-50649124254 10.1074/jbc.M710434200
21. Chowdhury B., Tsokos C. G., Krishnan S., Robertson J., Fisher C. U., Warke R. G., Warke V. G., Nambiar M. P., Tsokos G. C., Decreased stability and translation of T cell receptor ζ mRNA with an alternatively spliced 3′-untranslated region contribute to ζ chain down-regulation in patients with systemic lupus erythematosus. Journal of Biological Chemistry 2005 280 19 18959 18966 2-s2.0-21344456900 10.1074/jbc.M501048200 (Pubitemid 41379599)
22. Kyttaris V. C., Wang Y., Juang Y.-T., Weinstein A., Tsokos G. C., Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T cells from patients with systemic lupus erythematosus. Journal of Immunology 2007 178 3 1960 1966 2-s2.0-33846518435 (Pubitemid 46154669)
23. Kow N. Y., Mak A., Costimulatory pathways: physiology and potential therapeutic manipulation in systemic lupus erythematosus. Clinical and Developmental Immunology 2013 2013 12 245928 10.1155/2013/245928
24. Jury E. C., Kabouridis P. S., Flores-Borja F., Mageed R. A., Isenberg D. A., Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. Journal of Clinical Investigation 2004 113 8 1176 1187 2-s2.0-2142710163 10.1172/JCI200420345 (Pubitemid 38544103)
25. Janes P. W., Ley S. C., Magee A. I., Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. Journal of Cell Biology 1999 147 2 447 461 2-s2.0-0032727709 10.1083/jcb.147.2.447 (Pubitemid 29496350)
26. Janes P. W., Ley S. C., Magee A. I., Kabouridis P. S., The role of lipid rafts in T cell antigen receptor (TCR) signalling. Seminars in Immunology 2000 12 1 23 34 2-s2.0-0033998793 10.1006/smim.2000.0204 (Pubitemid 30114013)
27. Krishnan S., Nambiar M. P., Warke V. G., Fisher C. U., Mitchell J., Delaney N., Tsokos G. C., Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. Journal of Immunology 2004 172 12 7821 7831 2-s2.0-2942586874 (Pubitemid 38747650)
28. Deng G. M., Tsokos G. C., Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. Journal of Immunology 2008 181 6 4019 4026 2-s2.0-56149099718
29. Kammer G. M., Khan I. U., Malemud C. J., Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. Journal of Clinical Investigation 1994 94 1 422 430 2-s2.0-0028278214 (Pubitemid 24218121)
30. Mandler R., Birch R. E., Polmar S. H., Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America I 1982 79 23 7542 7546 2-s2.0-0020444252 (Pubitemid 13179143)
31. Tada Y., Nagasawa K., Yamauchi Y., Tsukamoto H., Niho Y., A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clinical Immunology and Immunopathology 1991 60 2 220 231 2-s2.0-0025871709 10.1016/0090-1229(91)90065-I
32. Matache C., Stefanescu M., Onu A., Tanaseanu S., Matei I., Frade R., Szegli G., p56(lck) activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus. Autoimmunity 1999 29 2 111 120 2-s2.0-0032587298 (Pubitemid 29192589)
33. Niculescu F., Nguyen P., Niculescu T., Rus H., Rus V., Via C. S., Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Arthritis and Rheumatism 2003 48 4 1071 1079 2-s2.0-0037388451 10.1002/art.10900 (Pubitemid 36418250)
34. Grolleau A., Kaplan M. J., Hanash S. M., Beretta L., Richardson B., Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. Journal of Clinical Investigation 2000 106 12 1561 1568 2-s2.0-0034519709 (Pubitemid 32038593)
35. Barber D. F., Bartolomé A., Hernandez C., Flores J. M., Redondo C., Fernandez-Arias C., Camps M., Rückle T., Schwarz M. K., Rodríguez S., Martinez-A C., Balomenos D., Rommel C., Carrera A. C., PI3K γ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nature Medicine 2005 11 9 933 935 2-s2.0-24744449495 10.1038/nm1291 (Pubitemid 41294437)
36. Cedeño S., Cifarelli D. F., Blasini A. M., Paris M., Placeres F., Alonso G., Rodriguez M. A., Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clinical Immunology 2003 106 1 41 49 2-s2.0-0037289364 10.1016/S1521-6616(02)00052-9 (Pubitemid 36263301)
37. Gorelik G., Jing Y. F., Wu A., Sawalha A. H., Richardson B., Impaired T cell protein kinase C δ activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. Journal of Immunology 2007 179 8 5553 5563 2-s2.0-38449104652
38. Sawalha A. H., Jeffries M., Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. European Journal of Immunology 2007 37 5 1407 1413 2-s2.0-34250376378 10.1002/eji.200636872 (Pubitemid 46925323)
39. Alcocer-Varela J., Alarcon-Segovia D., Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. Journal of Clinical Investigation 1982 69 6 1388 1392 2-s2.0-0019948507 (Pubitemid 12081067)
40. Crispín J. C., Oukka M., Bayliss G., Cohen R. A., Van Beek C. A., Stillman I. E., Kyttaris V. C., Juang Y.-T., Tsokos G. C., Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. Journal of Immunology 2008 181 12 8761 8766 2-s2.0-58849162766
41. Tenbrock K., Tsokos G. C., Transcriptional regulation of interlekin 2 in SLE T cells. International Reviews of Immunology 2004 23 3-4 333 345 2-s2.0-3042534462 10.1080/08830180490452558 (Pubitemid 38812234)
42. Gómez-Martín D., Díaz-Zamudio M., Crispín J. C., Alcocer-Varela J., Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmunity Reviews 2009 9 1 34 39
43. Solomou E. E., Juang Y.-T., Gourley M. F., Kammer G. M., Tsokos G. C., Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. Journal of Immunology 2001 166 6 4216 4222 2-s2.0-0035869333 (Pubitemid 32224956)
44. Juang Y.-T., Wang Y., Solomou E. E., Li Y., Mawrin C., Tenbrock K., Kyttaris V. C., Tsokos G. C., Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. Journal of Clinical Investigation 2005 115 4 996 1005 2-s2.0-16844376445 10.1172/JCI200522854 (Pubitemid 40489404)
45. Wadzinski B. E., Wheat W. H., Jaspers S., Peruski L. F. Jr., Lickteig R. L., Johnson G. L., Klemm D. J., Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Molecular and Cellular Biology 1993 13 5 2822 2834 2-s2.0-0027221605 (Pubitemid 23133954)
46. Katsiari C. G., Kyttaris V. C., Juang Y.-T., Tsokos G. C., Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. Journal of Clinical Investigation 2005 115 11 3193 3204 2-s2.0-27644546349 10.1172/JCI24895 (Pubitemid 41567584)
47. Juang Y.-T., Wang Y., Jiang G., Peng H.-B., Ergin S., Finnell M., Magilavy A., Kyttaris V. C., Tsokos G. C., PP2A dephosphorylates Elf-1 and determines the expression of CD3 ζ and FcR γ in human systemic lupus erythematosus T cells. Journal of Immunology 2008 181 5 3658 3664 2-s2.0-51549087191
48. Mak A., Almsherqi Z. A., Lai Y. W., Cheak A. A., Deng Y., Intracellular tubulo-reticular structures of peripheral blood mononuclear cells as an ultra-structural marker of disease activity in systemic lupus erythematosus: a pilot study. International Journal of the Rheumatic Diseases 2013 16 6 692 697
49. 2+ signaling profile of lupus T cells. Journal of Immunology 2004 173 6 3676 3683 2-s2.0-4644247643 (Pubitemid 39280728)
50. Fernandez D., Bonilla E., Mirza N., Niland B., Perl A., Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis and Rheumatism 2006 54 9 2983 2988 2-s2.0-33749345289 10.1002/art.22085 (Pubitemid 44497779)
51. Perl A., Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nature Reviews Rheumatology 2013 9 11 674 686
52. Scalapino K. J., Tang Q., Bluestone J. A., Bonyhadi M. L., Daikh D. I., Suppression of disease in New Zealand Black/New Zealand white lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. Journal of Immunology 2006 177 3 1451 1459 2-s2.0-33746214867 (Pubitemid 44092478)
53. La Cava A., Ebling F. M., Hahn B. H., Ig-reactive CD4+CD25+ T cells from toterized (New Zealand black × New Zealand white)F1 mice suppress in vitro production of antibodies to DNA. Journal of Immunology 2004 173 5 3542 3548 2-s2.0-4344634278 (Pubitemid 39142065)
54. La Cava A., T-regulatory cells in systemic lupus erythematosus. Lupus 2008 17 5 421 425 2-s2.0-44849130760 10.1177/0961203308090028 (Pubitemid 351798720)
55. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Nochy D., Debré P., Piette J.-C., Gorochov G., Global natural regulatory T cell depletion in active systemic lupus erythematosus. Journal of Immunology 2005 175 12 8392 8400 2-s2.0-29144516273 (Pubitemid 41798406)
56. Lyssuk E. Y., Torgashina A. V., Soloviev S. K., Nassonov E. L., Bykovskaia S. N., Reduced number and function of CD4+CD25 high FoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Advances in Experimental Medicine and Biology 2007 601 113 119 2-s2.0-34848898991 10.1007/978-0-387- 72005-0-12
57. Valencia X., Yarboro C., Illei G., Lipsky P. E., Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. Journal of Immunology 2007 178 4 2579 2588 2-s2.0-33846900430 (Pubitemid 46233461)
58. Sfikakis P. P., Souliotis V. L., Fragiadaki K. G., Moutsopoulos H. M., Boletis J. N., Theofilopoulos A. N., Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clinical Immunology 2007 123 1 66 73 2-s2.0-33947118656 10.1016/j.clim.2006.12.006 (Pubitemid 46401511)
59. Vigna-Perez M., Hernández-Castro B., Paredes-Saharopulos O., Portales-Pérez D., Baranda L., Abud-Mendoza C., González-Amaro R., Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Research and Therapy 2006 8 3, article R83 2-s2.0-70350525210 10.1186/ar1954
60. Cepika A.-M., Marinic I., Morovic-Vergles J., Soldo-Juresa D., Gagro A., Effect of steroids on the frequency of regulatory T Cells and expression of FoxP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 2007 16 5 374 377 2-s2.0-34447529156 10.1177/0961203307077990 (Pubitemid 47074842)
61. Golding A., Hasni S., Illei G., Shevach E. M., The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus. Arthritis Rheum 2013 65 11 2898 2906
62. Alexander T., Sattler A., Templin L., Kohler S., Groß C., Meisel A., Sawitzki B., Burmester G. R., Arnold R., Radbruch A., Thiel A., Hiepe F., Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Annals of the Rheumatic Diseases 2013 72 9 1549 1558
63. Singh R. P., la Cava A., Hahn B. H., pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB × NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules. Journal of Immunology 2008 180 4 2069 2080 2-s2.0-42149151044
64. Eilat E., Dayan M., Zinger H., Mozes E., The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 2001 98 3 1148 1153 2-s2.0-0035970048 10.1073/pnas.98.3.1148 (Pubitemid 32121201)
65. Filaci G., Bacilieri S., Fravega M., Monetti M., Contini P., Ghio M., Setti M., Puppo F., Indiveri F., Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. Journal of Immunology 2001 166 10 6452 6457 2-s2.0-0035873749 (Pubitemid 32440781)
66. Alvarado-Sánchez B., Hernández-Castro B., Portales-Pérez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., Cubillas-Tejeda A. C., González-Amaro R., Regulatory T cells in patients with systemic lupus erythematosus. Journal of Autoimmunity 2006 27 2 110 118 2-s2.0-33749520621 10.1016/j.jaut.2006.06.005 (Pubitemid 44528260)
67. Li X., Kang N., Zhang X., Dong X., Wei W., Cui L., Ba D., He W., Generation of human regulatory γ δ T cells by TCR γ δ stimulation in the presence of TGF- β and their involvement in the pathogenesis of systemic lupus erythematosus. Journal of Immunology 2011 186 12 6693 6700 2-s2.0-79959555285 10.4049/jimmunol.1002776
68. Austin H. A. III, Illei G. G., Braun M. J., Balow J. E., Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. Journal of the American Society of Nephrology 2009 20 4 901 911 2-s2.0-65249125804 10.1681/ASN.2008060665
69. Moroni G., Doria A., Mosca M., Alberighi O. D. C., Ferraccioli G., Todesco S., Manno C., Altieri P., Ferrara R., Greco S., Ponticelli C., A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clinical Journal of the American Society of Nephrology: CJASN 2006 1 5 925 932 2-s2.0-34548454046 10.2215/CJN.02271205
70. Chen W., Tang X., Liu Q., Chen W., Fu P., Liu F., Liao Y., Yang Z., Zhang J., Chen J., Lou T., Fu J., Kong Y., Liu Z., Fan A., Rao S., Li Z., Yu X., Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: a multicenter randomized clinical trial. The American Journal of Kidney Diseases 2011 57 2 235 244 2-s2.0-78751610590 10.1053/j.ajkd.2010.08.036
71. Kalunian K. C., Davis J. C. Jr., Merrill J. T., Totoritis M. C., Wofsy D., Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 2002 46 12 3251 3258 2-s2.0-0036899589 10.1002/art.10681 (Pubitemid 35453534)
72. Boumpas D. T., Furie R., Manzi S., Illei G. G., Wallace D. J., Balow J. E., Vaishnaw A., A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis and Rheumatism 2003 48 3 719 727 2-s2.0-0037333857 10.1002/art.10856 (Pubitemid 36302008)
73. Lai Z. W., Borsuk R., Shadakshari A., Yu J., Dawood M., Garcia R., Francis L., Tily H., Bartos A., Faraone S. V., Phillips P., Perl A., Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. The Journal of Immunology 2013 191 5 2236 2246
74. Lai Z. W., Hanczko R., Bonilla E., Caza T. N., Clair B., Bartos A., Miklossy G., Jimah J., Doherty E., Tily H., Francis L., Garcia R., Dawood M., Yu J., Ramos I., Coman I., Faraone S. V., Phillips P. E., Perl A., N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatology 2012 64 9 2937 2946